Biotech News
-
Zentek’s Rapid Diagnostic Platform Receives Two NSERC Grants Towards Commercialization
May 19, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK; TSX-V:ZEN), an intellectual property development and commercialization company,…
-
Awakn Life Sciences Completes World’s First Ketamine Treatment Study for a Range of Behavioral Addictions
Promising Results Merit Larger Study Which Awakn is Initiating May 19, 2022 (Source) – Awakn Life Sciences Corp. (NEO:…
-
Sixth Wave Signs MOU with Retro Cannabis and Hemp Extracts for Delivery of Affinity(TM) Production and Commercial Demonstration Facility
May 19, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave” or the “Company”) is pleased…
-
Voyageur Pharmaceuticals Completes Milestone with the FDA and Continues to Move Towards Commercialization on Three Fronts
May 18, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (“Voyageur” or the “Company”) (TSXV:VM) is pleased to announce that it is…
-
Awakn Life Sciences Appoints UK Leader in Addictions Psychiatry, Dr. Arun Dhandayudham, as Chief Medical Officer
Dr. Dhandayudham Brings Significant Frontline Addiction and Mental Health Medical Leadership Experience to Awakn May 17, 2022 (Source)…
-
Sixth Wave Confirms Delivery of Affinity(TM) System
May 17, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or the…
-
Hemostemix Announces Rick Groome as Special Advisor to The CEO
May 16, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to…
-
Zentek Announces Sales and Distribution of ZenGUARD(TM) Masks through Mark’s in Canada
May 13, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces…
-
Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares to Pay for Deposits and Debt
May 10, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the “Company” or “Voyageur”) has agreed to pay deposits for…
-
Hemostemix Announces Its Intellectual Property is Back Home
May 10, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased…
